Neuroscience

M.M. Dugich-Djordjevic, G. Tocco, D.A. Willoughby, I. Najm, G. Pasinetti, R.F. Thompson, M. Baudry, P.A. Lapchak, F. Hefti, "BDNF mRNA expression in the developing rat brain following kainic acid-induced seizure activity," Neuron, 8:1127-38, 1992. Franz Hefti (Andrus Gerontology Center, University of Southern California, Los Angeles): "The discovery of the neurotrophin growth factor family, which includes nerve growth factor (NGF),

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Franz Hefti (Andrus Gerontology Center, University of Southern California, Los Angeles): "The discovery of the neurotrophin growth factor family, which includes nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophine-4/5 (NT-4/5), and the realization that BDNF and NT3 and their receptors are expressed at high levels in the brain, led us to hypothesize that these factors play a role in plasticity of the adult brain. Four years ago, we entered this field pooling our expertise in neurotrophic factors with that in plasticity and learning of the labs of Richard Thompson and Michel Baudry at USC. As did other groups, we found that the expression of BDNF and NT-3 are regulated in vivo by intense neuronal activity. Pharmacologically induced seizures in rats and seizure activity associated with epilepsy in humans result in structural changes within certain forebrain structures. Thus, our findings suggested that pathological and, perhaps, physiological neuronal ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies